AUTHOR=Yu Baofa , Han Yan , Zhang Jian , Chen Dong TITLE=Formation of self-nanoparticles and the immune effect on tumors after injection of ferric chloride with H2O2 under magnetic field therapy JOURNAL=Frontiers in Nanotechnology VOLUME=6 YEAR=2024 URL=https://www.frontiersin.org/journals/nanotechnology/articles/10.3389/fnano.2024.1465888 DOI=10.3389/fnano.2024.1465888 ISSN=2673-3013 ABSTRACT=Objective

Nanotechnology offers many advantages in various fields of cancer therapy. This study describes a new method of self-forming nanoparticles (self-nano) using ferric chloride (FeCl₃) and hydrogen peroxide (H2O2) to form the self-nanoparticles in an in vivo tumor. The treatment effect is evaluated.

Method

A solution of 3% FeCl3 (0.5 mL) and 1.8% H2O2 (1.0 mL) was injected into the tumor. At various time points post-injection, tumors were collected, and sections were prepared for electron microscopy to evaluate the size of the self-nano particles. Single-cell RNA sequencing (scRNA-seq) was used to analyze the immune changes and their effect on tumor growth.

Result

The formation of self-nano in vitro was observed and confirmed, with particles averaging 421 nm in size for the FeCl3 + H2O2 solution. Over time points ranging from 1 to 14 days, the formed self-nano remained stable at a regular size of 421 ± 8 nm. The self-nano, primarily consisting of iron, induced ferroptosis under the influence of an external magnetic field, leading to tumor growth control through iron-induced cell death and immune reactions. These self-nanoparticles also showed stronger enrichment of pathways related to CD8+ T effect cells (Teff), T cell activation, and regulation of T cell proliferation.

Conclusion

The FeCl3 + H2O2 solution can form Fe₂O₃-based self-nanoparticles within tumors through H2O2-incubated oxidation of FeCl3. The self-nano remains effective for over 14 days, inducing ferroptosis and upregulating immune cells under magnetic field treatment. This method offers a novel approach for cancer treatment that can be combined with other modalities.